Dihydroartemisinin Attenuates Radiation‐Induced Lung Injury by Inhibiting the cGAS/STING/NF‐κB Signaling Pathway
Drug Development Research · 2025-05 · 86 (3)
DOI: 10.1002/ddr.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 26.04.2025. Verfasst von Cailan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China. Hauptthemen laut MEDLINE: Nucleotidyltransferases, NF-kappa B, Artemisinins, Membrane Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The study was supported by the National Natural Science Foundation of China [No. 82060576]..
Abstract (Originalsprache)
Dihydroartemisinin (DHA) is a derivative of artemisinin, which affects inflammation, oxidative stress, and immune regulation. However, the mechanism underlying its effects remains largely unknown. This study aims to explore the mechanism by which DHA affects radiation‐induced lung injury (RILI), providing new insights for lung radiotherapy. To elucidate its mechanism of action, C57BL/6 J mice were irradiated with 15 Gy whole chest. RILI was evaluated by qRT‐PCR, ELISA, histology, Western blot analysis, immunohistochemistry, and RILI signaling cascade studies. In addition, small interfering RNAs were employed to knockdown cGAS proteins in the cGAS‐STING signaling pathway in the human bronchial epithelium cell line (BEAS‐2B). Both In Vivo and Vitro experiments were conducted to investigate the specific mechanism by which DHA alleviated RILI. We observed the activation of the cGAS‐STING pathway, along with the phosphorylation of the downstream target NF‐κB and an increase in inflammatory factor levels in the mouse model following radiation exposure. In the cell model, irradiation also triggered the activation of the cGAS‐STING signaling pathway and its downstream targets, leading to elevated levels of inflammatory factors. Notably, knocking down the cGAS using small interfering RNA in the BEAS‐2B cells significantly alleviated RILI in the cell model. Our study elucidated the mechanism of DHA reducing RILI through the cGAS/STING/NF‐κB signaling pathway, and revealed that the GAS/STING/NF‐κB axis may be a potential therapeutic target for RILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
ORCID-Profile: Shixiong Liang
Förderung
- The study was supported by the National Natural Science Foundation of China [No. 82060576].
Zitieren
APA
Wang, C., Lin, X., Guan, S., Wu, Q., & Liang, S. (2025). Dihydroartemisinin Attenuates Radiation‐Induced Lung Injury by Inhibiting the cGAS/STING/NF‐κB Signaling Pathway. Drug Development Research, 86(3). https://doi.org/10.1002/ddr.70090
Vancouver
Wang C, Lin X, Guan S, Wu Q, Liang S. Dihydroartemisinin Attenuates Radiation‐Induced Lung Injury by Inhibiting the cGAS/STING/NF‐κB Signaling Pathway. Drug Development Research. 2025;86(3). doi:10.1002/ddr.70090
BibTeX
@article{Wang2025,
author = {Wang, Cailan and Lin, Xinyi and Guan, Shichun and Wu, Qiaoyuan and Liang, Shixiong},
title = {Dihydroartemisinin Attenuates Radiation‐Induced Lung Injury by Inhibiting the cGAS/STING/NF‐κB Signaling Pathway},
journal = {Drug Development Research},
year = {2025},
volume = {86},
number = {3},
doi = {10.1002/ddr.70090}
}
EUVIMED